$572M ruling in Oklahoma opioid case could spell trouble for Triangle pharmas

A judge's ruling in Oklahoma could mean bad news for opioid companies across the country – including those in the Triangle.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.